a 3D rendered illustration of  the anatomical location of a breast tumor in red with extending blood vessels.

Breast cancer cells consume extracellular matrix to proliferate in low nutrient environments.

credit: istock.com/xrender

Breast cancer cells adapt to survive despite starvation

The extracellular matrix provides breast cancer cells vital amino acids that allow the cells to grow and thrive when nutrients are scarce.
| 3 min read
Written byLuisa Torres, PhD
Register for free to listen to this article
Listen with Speechify
0:00
3:00

Embedded in a thick wall of collagen and other extracellular matrix materials, cancer cells starve when out of reach of the blood supply that transports vital nutrients (1). In the case of breast cancer, hungry tumor cells survive by consuming the extracellular matrix surrounding them, according to a recent study published in PLOS Biology (2).

3D illustration of a migrating breast cancer cell
Breast cancer cells consume extracellular matrix to proliferate in low nutrient environments.
credit: Keqian Nan

Lead investigator and biotechnologist Elena Rainero at the University of Sheffield studied how the extracellular matrix around cancer cells affected how cancers spread, but an interesting observation made her refocus her efforts: “I started to notice that the [cancer] cells were not just binding to the matrix, but they were also taking it inside,” she said. “If they're doing that, they must have a reason.” What she and her team found sheds light on a potential vulnerability in cancer cells and suggests possible new targets for therapeutic interventions.

Rainero’s team cultured a human breast cancer cell line and a metastatic breast cancer cell line on three different materials: collagen I, Matrigel, or plastic. Collagen I is an extracellular matrix component, while Matrigel is a protein mixture designed to mimic the extracellular matrix. To find out how cancer cells grow under starvation, they used either nutrient-rich media or media lacking amino acids. Compared to plastic, collagen I and Matrigel supported cell growth even when nutrients were scarce, suggesting that the extracellular matrix partially rescues cell growth during nutrient deprivation.

Rainero was surprised at the results. “I was expecting that if you removed a lot of nutrients, the cells would just die,” she said. “Apparently, cancer cells don't do that. They are really efficient at using whatever they have access to.”

Continue reading below...
An illustration showing red cancer cells surrounded by white immune cells interacting on a dark textured background.
ExplainersWhy does immunotherapy work better for some cancers than others?
A powerful tool in modern oncology, immunotherapy doesn’t work the same for everyone. Researchers are exploring why and developing ways to improve its effectiveness.
Read More

When the team fluorescently labeled the collagen to track its journey inside the cancer cells, the researchers found that the ingested material accumulated inside lysosomes. There, it was degraded and used to derive essential amino acids, such as phenylalanine and tyrosine, which the cancer cells used to continue growing. “It’s always a bit surprising how fast the extracellular matrix can degrade in a tumor,” said Paolo Provenzano, a biomedical engineer at the University of Minnesota, who was not involved in the study. “This could be part of that missing puzzle; it's not all just getting degraded by classical enzymatic approaches. Instead, a lot of it is being metabolized by the cancer cells themselves.”

I was expecting that if you removed a lot of nutrients, the cells would just die. Apparently, cancer cells don't do that. They are really efficient at using whatever they have access to.
– Elena Rainero, University of Sheffield

Rainero’s team showed that one possible mechanism through which cancer cells ingested extracellular matrix material was macropinocytosis, a form of endocytosis through which cells engulf extracellular molecules (3). Blocking or reducing expression of the macropinocytosis promoter p21-activated kinase reduced Matrigel uptake and cancer cell growth under nutrient deprivation conditions.

In future experiments, Rainero’s team plans to inhibit amino acid metabolism in an animal cancer model to see whether tumor growth is affected. In parallel, they would also like to test whether extracellular matrix uptake occurs in other highly fibrotic cancer types such as pancreatic tumors. Provenzano added, “I suspect that a lot of [the] mechanisms [these researchers uncovered] are applicable to a broad range of breast cancer cells, and even to broader cancers, but we [need] the experiments to find out.”

References

  1. Kamphorst, J. J. et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res 75, 544–553 (2015).
  2. Nazemi, M. et al. The extracellular matrix supports breast cancer cell growth under amino acid starvation by promoting tyrosine catabolism. PLOS Bio 22, e3002406 (2024).
  3. Kay, R. R. Macropinocytosis: Biology and mechanisms. Cells Dev 168, 203713 (2021).
Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

  • Luisa Torres

    Luisa is an assistant science editor at Drug Discovery News. She has a PhD in Molecular and Cellular Pharmacology from Stony Brook University where she researched anti-inflammatory treatments for spinal cord injury. Later, as a postdoctoral fellow, she studied how parasitic infections may lead to signs of Alzheimer’s disease. She has written for NPR’s blogs ‘Shots’, ‘The Salt ‘and ‘Goats and Soda’. Her interests include metabolism, aging and drug discovery.

    View Full Profile

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A network of interconnected human icons overlaid on a world map, representing global collaboration and population-scale data connections.
New collaborative initiatives are bringing pharmaceutical R&D together around large-scale datasets to accelerate therapeutic discovery.
Modeling neurotropic viral infections using human cerebral organoids
Using fetal-stage brain organoids, researchers are uncovering how Zika virus impacts neurodevelopment and contributes to microcephaly. 
Completing the real-time data picture in bioprocess development
Explore approaches to integrating timely protein titer measurements with cell health data to improve bioprocess visibility and decision-making.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue